Erlocent(Erlotinib)
Therapeutic Group: Oncology Presentation Erlocent 100: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 100 mg. Erlocent 150: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 150 mg. Description Erlotinib, a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)4-quinazolinamine. Erlotinib reversibly inhibits the kinase activity of EGFR, preventing autophosphorylation of tyrosine […]